product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Bcr Antibody
catalog :
3902
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, immunocytochemistry, flow cytometry
citations: 6
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig 7a
Chennupati V, Veiga D, Maslowski K, Andina N, Tardivel A, Yu E, et al. Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation. J Clin Invest. 2018;128:1597-1614 pubmed publisher
  • western blot; mouse; loading ...; fig 2e, 2c, 2g
Brahmachari S, Ge P, Lee S, Kim D, Karuppagounder S, Kumar M, et al. Activation of tyrosine kinase c-Abl contributes to ?-synuclein-induced neurodegeneration. J Clin Invest. 2016;126:2970-88 pubmed publisher
  • western blot; human; fig 2
Crivellaro S, Panuzzo C, Carrà G, Volpengo A, Crasto F, Gottardi E, et al. Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion. Oncotarget. 2015;6:25217-25 pubmed publisher
  • western blot; mouse; fig 4a
Huang P, Chen C, Hsu I, Salim S, Kao S, Cheng C, et al. Huntingtin-associated protein 1 interacts with breakpoint cluster region protein to regulate neuronal differentiation. PLoS ONE. 2015;10:e0116372 pubmed publisher
Zabriskie M, Vellore N, Gantz K, Deininger M, O Hare T. Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1. Leukemia. 2015;29:1939-42 pubmed publisher
O Hare T, Zabriskie M, Eide C, Agarwal A, Adrian L, You H, et al. The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia. Blood. 2011;118:5250-4 pubmed publisher
product information
SKU :
3902S
Product-Name :
Bcr Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Pg
Applications :
Flow cytometry
Product-Category :
MAP Kinase Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
130, 160 (Bcr); 210 (Bcr-Abl)
Host :
Rabbit
Target :
Bcr
Primary-Protein :
Bcr
Alt-Names :
ALL,BCR,BCR1,Breakpoint cluster region protein,CML,D22S11,D22S662,FLJ16453,PHL,Renal carcinoma antigen NY-REN-26,breakpoint cluster region
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.